Lasik Market

Laser Eye Surgery News

Pac-10 ConferenceFriday, March 12, 2010 @ 3:51AMPac-10 Conference-Around the Pac 10

PAINTER: UCLA freshman takes a good look at his fears, then overcomes themFriday, March 12, 2010 @ 1:35AMFor the first time, Reeves Nelson was scared to play basketball. Nelson didn't utter those exact words, but his mom, Sheila Nelson, sensed it.

The Harley Medical Group Finds Awards Season Driving Demand for Eyebrow LiftsFriday, March 12, 2010 @ 1:01AMThe Harley Medical Group has revealed the latest must-have look, as on the catwalk and the silver screen, celebrities are donning a new accessory this season - statement eyebrows.

UCLA beats Arizona in Pac-10 tournament openerFriday, March 12, 2010 @ 12:39AMThe Bruins welcome back Reeves Nelson from injury and usher the Wildcats out of the tourney. The Bruins welcome back Reeves Nelson from injury and usher the Wildcats out of the tourney.

UCLA beats Arizona in Pac-10 tournament openerFriday, March 12, 2010 @ 12:35AMBruins forward Nikola Dragovic gives a high-five to guard Michael Roll after he hit a key three-pointer in the second half Thursday. Dragovic and Roll each finished with 18 points.

Clyde F. Newman Jr., 87, Main Line ob/gynThursday, March 11, 2010 @ 6:03PMClyde Fairfax Newman Jr., 87, a gynecologist and obstetrician on the Main Line for 40 years, died of heart failure March 3 at White Horse Village, a retirement community in Newtown Square.

UCLA defeats Arizona, 75-69, in Pac-10 tournamentThursday, March 11, 2010 @ 5:26PMReeves Nelson finishes with 19 points and 11 rebounds in his first game since undergoing eye surgery.

Devolin recovering after eye surgeryThursday, March 11, 2010 @ 11:10AMHaliburton-Kawartha Lakes-Brock MP Barry Devolin is recovering in Ottawa following unscheduled surgery. Devolin learned March 5 he had a detached retina – a serious problem that could cause permanent loss of vision.

pSivida Reports Presentation Of Additional Positive 24-Month Data From Iluvien(R) Phase 3 FAME™ Study For Diabetic ...Friday, March 5, 2010 @ 8:42AMpSivida Corp. (NASDAQ:PSDV) (ASX:PVA) (FF:PV3), a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the ...